Michael Lim
Impact in
- Genetics top 0.05%
- Glioma Diagnosis and Treatment
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Co-authors
- Chetan Bettegowda (72 shared papers)Christopher M. Jackson (49 shared papers)Michael Weller (14 shared papers)John Choi (26 shared papers)Yuanxuan Xia (18 shared papers)Charles G. Drake (9 shared papers)Jonathan W. Simons (5 shared papers)Gregg L. Semenza (1 shared paper)
- Journals
- Neuro-Oncology (26 papers)International Journal of Radiation Oncology*Biology*Physics (25 papers)Neurosurgery (24 papers)World Neurosurgery (19 papers)Journal of Clinical Oncology (17 papers)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Michael Lim
385 papers receiving 17.8k citations
Michael Lim's Hit Papers
Peers
Comparison fields: 5 of 188
- Genetics 4.7k
- Immunology 3.9k
- Oncology 4.6k
- Cancer Research 2.5k
- Neurology 1.3k
Countries citing papers authored by Michael Lim
This map shows the geographic impact of Michael Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lim more than expected).
Fields of papers citing papers by Michael Lim
This network shows the impact of papers produced by Michael Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lim. The network helps show where Michael Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 404 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Hit paper breakdown → | 1999 | 1976 |
| 2 | Current state of immunotherapy for glioblastoma Hit paper breakdown → | 2018 | 992 |
| 3 | Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma Hit paper breakdown → | 2020 | 992 |
| 4 | Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy Hit paper breakdown → | 2015 | 694 |
| 5 | Mechanisms of immunotherapy resistance: lessons from glioblastoma Hit paper breakdown → | 2019 | 546 |
| 6 | 1994 | 421 | |
| 7 | Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. | 1999 | 399 |
| 8 | Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma Hit paper breakdown → | 2013 | 397 |
| 9 | Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143 Hit paper breakdown → | 2017 | 376 |
| 10 | 2015 | 307 | |
| 11 | Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Hit paper breakdown → | 2017 | 252 |
| 12 | 2017 | 245 | |
| 13 | 2016 | 245 | |
| 14 | Glioma Hit paper breakdown → | 2024 | 241 |
| 15 | 2017 | 210 | |
| 16 | 2020 | 207 | |
| 17 | 2013 | 186 | |
| 18 | 2014 | 185 | |
| 19 | 2020 | 180 | |
| 20 | 2014 | 168 |
About Michael Lim
Michael Lim is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Immunology and Pathology and Forensic Medicine, having authored 404 papers that have together received 18.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (127 papers), Cancer Immunotherapy and Biomarkers (73 papers), Brain Metastases and Treatment (53 papers), Trigeminal Neuralgia and Treatments (52 papers), Immunotherapy and Immune Responses (46 papers), Meningioma and schwannoma management (39 papers), CAR-T cell therapy research (25 papers) and Immune cells in cancer (23 papers). The work is most often cited by research in Genetics (4.7k citations), Immunology (3.9k citations), Oncology (4.6k citations), Cancer Research (2.5k citations) and Neurology (1.3k citations). Michael Lim has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Chetan Bettegowda, Christopher M. Jackson, Michael Weller, John Choi, Yuanxuan Xia, Charles G. Drake, Jonathan W. Simons, Gregg L. Semenza, Peter Buechler and Angelo M. De Marzo. Their work appears in journals such as Neuro-Oncology, International Journal of Radiation Oncology*Biology*Physics, Neurosurgery, World Neurosurgery and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.